were similar to ZIKV alone infected animals in addition to minimal changes of cytokines.
3
Dynamics of SIV and SHIV also did not change. Tissue clearance of ZIKV was found 6- inoculation (dpi) with ZIKV (Fig 1A) , blood samples were collected and centrifuged to 2, S1 Table) . was performed according to the study plan on 0, 4, 7, 9, 15, 26 and 51 days post cytokines/chemokines were normalized to the mean of the baselines (S1A Table) , log2-1 6 2 transformed (S1B Table) and then subjected to hierarchical clustering; heat maps were interferon-α and -γ; IL, interleukin; SDF-1α, stromal cell-derived factor. replication were used to compare various data presented in this study. of all the chronically infected SIV macaques were stable (10 5 -10 7 copies/ml) and 1 7 5
maintained as before ZIKV inoculation as shown in SIVmac239 (Fig 1B) . However, 1 7 6 their ZIKV plasma viral loads were found to peak up to 10 5 copies/ml on 7 dpi ( Fig 1C) . ZIKV was detected in plasma samples up to 9 dpi in two of SIV-ZIKV co-infected 1 7 8 animals; <10 4 copies/ml for RMo15R and > 10 2 copies/ml for REd15R on 9 dpi. RGm15R that had the highest viral load, > 10 5 copies/ml on 7 dpi, and was found 1 8 0 negative to ZIKV on 9 dpi ( Fig 1C) . Interestingly, REd15R, with the lowest peak of ZIKV 1 8 1 viral load of > 10 2 copies/ml, detected ZIKV up to 15 dpi ( Fig 1C) . Furthermore, the SIV 1 8 2 viral load status of these four SIV-ZIKV co-infected RMs were similar and quite stable 1 8 3 during 51 dpi with ZIKV ( Fig 1B) . In SHIV-ZIKV confected RMs, SHIV plasma viral loads were also found quite 1 8 5 stable 10 2 -10 3 copies/ml during 20 dpi with ZIKV ( Fig 1D) . Also, their ZIKV plasma viral 1 8 6
loads were found to peak on 3 dpi to 10 3 copies/ml for R21612R animal and 10 4 1 8 7 copies/ml for RZi15R animal (Fig 1E) . On 5 dpi, ZIKV was only detected at lower levels, 1 8 8 < 10 3 copies/ml, in RZi15R; after that and up to end of study, ZIKV was not found in 1 8 9
RMs R21612R and RZi15R (Fig 1E) .
Viral loads of ZIKV in all six co-infected RMs in this study were found negative 1 9 1 after 20 days onwards; however, this delay of self-recovery of viremia is longer in co- requires more epidemiological studies. Clinical investigation of co-infected RMs did not 1 9 9
show any severe symptoms and/or clinical signs of ZIKV infection with permanent 2 0 0 sequelae after acute phase (≤ 9 dpi). Additionally, at necropsy 6-7 months post suggesting that ZIKV infection had been cleared in these animals (data not shown). show that with the exception of MIF, IL-8, and SDF-1α, significant elevations of the 2 1 3 serum interleukin concentrations are evident in the acute phase of ZIKV especially at 2 1 4 the peak on 7 dpi. Many of the cytokines and chemokines that were elevated in the 2 1 5 acute phase of ZIKV showed a tendency to return to normal levels in the later recovery recovery phase, were minor for MCP-1, IL-5, and IL-7 (Fig 2, S1 Table) . The main objective of this study is to understand the dynamics of HIV-ZIKV coinfection other. We used rhesus macaques chronically infected with either SIVmac239 or 2 2 8 SHIV3618MTF. These macaques were then inoculated with 10 4 PFU of ZIKV have been observed in our previous studies as well as chronically infected RMs in kinetics in these co-infected RMs were also similar to those in the SIV/SHIV infected 10, MCP-1, RANTES, I-TAC, SDF-1α, and GRO-α) were also elevated during the ZIKV 2 7 7 infection in chronically SIV/SHIV infected RMs described in this study. These recruitment to the sites of infection were highly triggered in SIV-ZIKV co-infected RMs.
8 5
However, there were no significant changes between any of the cytokine levels 2 8 6 measured in the acute versus the recovery phase. In summary, we showed that ZIKV viremia dynamics in chronically SIV/SHIV RMs did 
